Skip to main content

House bill · H.R. 4605 (119th Congress)

End Prescription Drug Ads Now Act

U.S. House of Representatives

Latest action Jul 22, 2025

Sponsor: Jerrold Nadler (U.S. Representative, NY-12, Democratic)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

Amends the Federal Food, Drug, and Cosmetic Act to bar manufacturers of approved prescription drugs and biologics from direct-to-consumer advertising, including on social media, by treating a drug as misbranded if its manufacturer advertised it to consumers within the prior 30 days.

AI summary. Not an official summary. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

2

Cosponsors listed on Congress.gov, shown A to Z.

  • Democratic2

Shown in neutral colors by design; Agora is non-partisan.

As identified by Congress.gov.

Full history

  1. Jul 22, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  2. Jul 22, 2025

    Introduced

    Introduced in U.S. House

    U.S. House

  3. Jul 22, 2025

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    U.S. House of Representatives

Read the record